Stockscreener 앱 받기
1.245
3.32%
0.04
Pmv Pharmaceuticals Inc 주식(PMVP)의 최신 뉴스
PMV Pharmaceuticals (PMVP) upgraded to buy: Here's why - MSN
PMV Pharmaceuticals holds the focus as investors await the next catalyst. - AD HOC NEWS
Price to earnings forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Enterprise value to revenue forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Price to book forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Enterprise value to EBIT forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
PMV Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:PMVP) - TradingView
PMVP Forecast — Price Target — Prediction for 2027 - TradingView
PMV Pharmaceuticals Inc (PMVP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's Why - Yahoo Finance
PMV Pharmaceuticals Inc (PMVP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PMV Pharmaceuticals Inc (PMVP) Valuation: PE, PB & Fair Value Analysis - TradingKey
PMV Pharmaceuticals Inc (PMVP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PMV Pharmaceuticals Inc (PMVP) Institutional Confidence - TradingKey
PMV Pharmaceuticals Inc (PMVP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PMV Pharmaceuticals Inc (PMVP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PMV Pharmaceuticals Inc (PMVP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PMV Pharmaceuticals Inc (PMVP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PMVP Q1 2026 Earnings: Narrower-Than-Expected Loss Mitigates Stock DeclineEarnings Risk Report - newsline.com
PMVP SEC FilingsPmv Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
PMV Pharmaceuticals Stock (US7301281085): Quiet session puts fundamentals and balance sheet in focus - AD HOC NEWS
PMV Pharmaceuticals (PMVP) loses 26% in 4 weeks, here's why a trend reversal may be around the corner - MSN
PMV Pharmaceuticals (PMVP) Q1 2026 Earnings: EPS Beat Driven by Tight Cost Control, Stock Slips on Lack of RevenueEarnings Quality Score - newsline.com
PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
PMV Pharmaceuticals Slips Slightly as Shares Approach Critical SupportCounter Trend Trade - newsline.com
PMV Pharmaceuticals (PMVP) Dips 3.5% as Stock Tests Key Support at $1.0Golden Cross - dars.gov.et
PMV Pharmaceuticals (PMVP) grants director 42,000 options at $1.19 - Stock Titan
PMV Pharmaceuticals (PMVP) director receives 42,000 stock options at $1.1900 - Stock Titan
PMV Pharmaceuticals (PMVP) director gifts 84K stock options to trust - Stock Titan
PMV Pharmaceuticals (PMVP) director awarded 42,000 stock options at $1.19 - Stock Titan
Director at PMV Pharmaceuticals (PMVP) granted 42,000 options at $1.19 - Stock Titan
PMV Pharmaceuticals, Inc. Files Form 8-K with SEC Detailing Company Information and Annual Meeting Results - Minichart
PMV Pharmaceuticals Shareholders Back Directors and Governance Matters - TipRanks
Shareholders back PMV Pharmaceuticals (NASDAQ: PMVP) board, pay plans - Stock Titan
PMVP: Directors elected, compensation and auditor ratified, with no stockholder questions raised - TradingView
PMV Pharmaceuticals Inc Annual Shareholders Meeting Transcript - GuruFocus
PMV Pharmaceuticals Q1 2026 Earnings: EPS Beat Narrows Losses Amid Pre-Revenue Pipeline ProgressEarnings Season Outlook - newsline.com
PMVP Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SurpriseNext Quarter Guidance - newsline.com
PMV Pharmaceuticals Advances Cancer Study Amid Adjusted Financial Targets - asatunews.co.id
PMV Pharmaceuticals Advances Cancer Drug Development Amid Financial Adjustments - sekbernews.id
Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity - Insider Monkey
5 Popular Penny Stocks on Robinhood to Watch in 2026 - Insider Monkey
PMVPPMV Pharmaceuticals Inc Latest SEC Filings - Finviz
PMVP Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline ProgressesEarnings Seasonality - dars.gov.et
PMVP Q1 2026 Earnings: Narrower Loss Slightly Beats Estimates as Development AdvancesRevenue Miss Report - The Legal Advocate
PMV Pharmaceuticals’ Phase 2 Clinical Trial Progresses; Reports $5 Million in First-Quarter Revenue - geneonline.com
PMV Pharmaceuticals (PMVP) Slips to $1.26 as Cautious Trading Puts Support to the TestCalendar Spread Trade - Newser
PMV Pharmaceuticals, Inc.Common Stock (Nasdaq:PMVP) Stock Quote - FinancialContent
PMV Pharmaceuticals (PMVP) Q1 2026 Earnings Surprise: EPS $-0.34, Up SignificantProfit Cycle Analysis - The Legal Advocate
Number of shareholders of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Euclidean Capital reports 2.6M shares in PMVP (PMVP) - Stock Titan
PMV Pharmaceuticals (PMVP) Q1 2026 Earnings: Why the Beat MattersShared Trade Ideas - newser.com
PMV Pharmaceuticals (PMVP) price target decreased by 37.50% to 4.84 - MSN
PMVP Maintains Outperform Rating by Oppenheimer -- Price Target Lowered to $5.00 - GuruFocus
Oppenheimer Maintains PMV Pharmaceuticals(PMVP.US) With Buy Rating, Cuts Target Price to $5 - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market SessionAquestive Therapeutics (NASDAQ:AQST) - Benzinga
Oppenheimer Adjusts Price Target on PMV Pharmaceuticals to $5 From $6, Maintains Outperform Rating - marketscreener.com
Analysts Offer Insights on Healthcare Companies: PMV Pharmaceuticals (PMVP) and Mereo Biopharma Group Plc (MREO) - The Globe and Mail
TradingKey - TradingKey
1.83%
3.59%
자본화:
|
볼륨(24시간):